100 related articles for article (PubMed ID: 29201)
1. Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats.
Biggio G; Corda MG; Casu M; Gessa GL
Life Sci; 1978 Aug; 23(6):649-52. PubMed ID: 29201
[No Abstract] [Full Text] [Related]
2. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
Breese GR; Mueller RA; Mailman RB
J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
[No Abstract] [Full Text] [Related]
3. Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
Breese GR; Mailman RB; Ondrusek MG; Harden TK; Mueller RA
Life Sci; 1978 Aug; 23(5):533-6. PubMed ID: 29192
[No Abstract] [Full Text] [Related]
4. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
5. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
Burkard WP; Pieri L; Haefely W
Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
[TBL] [Abstract][Full Text] [Related]
6. In vivo changes of guanosine 3',5'-cyclic phosphate in rat cerebellum by dopaminergic mechanisms.
Burkard WP; Pieri L; Haefely W
J Neurochem; 1976 Jul; 27(1):297-8. PubMed ID: 182922
[No Abstract] [Full Text] [Related]
7. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content.
Mailman RB; Mueller RA; Breese GR
Life Sci; 1978 Aug; 23(6):623-7. PubMed ID: 211362
[No Abstract] [Full Text] [Related]
8. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
Biggio G; Costa E; Guidotti A
Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
[No Abstract] [Full Text] [Related]
9. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Biggio G; Corda MG; Casu M; Gessa GL
Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
[No Abstract] [Full Text] [Related]
10. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
Biggio G; Guidotti A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
[TBL] [Abstract][Full Text] [Related]
11. Morphine reduces cerebellar guanosine-3',5'-cyclic monophosphate content and elevates cerebrospinal fluid guanosine-3',5'-cyclic monophosphate content in rhesus monkey.
Katz JB; Catravas GN; Valases C; Wright SJ
Life Sci; 1978 Feb; 22(6):467-72. PubMed ID: 203814
[No Abstract] [Full Text] [Related]
12. Ethanol-induced depletion of cerebellar guanosine 3',5' -cyclic monophosphate.
Redos JD; Catravas GN; Hunt WA
Science; 1976 Jul; 193(4247):58-9. PubMed ID: 180596
[TBL] [Abstract][Full Text] [Related]
13. CCK modulation of cerebellar afferents: dopaminergic involvement.
Wood PL
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
Puri SK; Choma P; Volicer L
Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
[No Abstract] [Full Text] [Related]
15. Brain nucleotides in naive and handling-habituated rats: differences in levels and drug-sensitivity.
Corda MG; Biggio G; Gessa GL
Brain Res; 1980 Apr; 188(1):287-90. PubMed ID: 6245755
[No Abstract] [Full Text] [Related]
16. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
Biggio G; Guidotti A
Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
[No Abstract] [Full Text] [Related]
17. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
Mailman RB; Frye GD; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
[TBL] [Abstract][Full Text] [Related]
18. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses.
Lundberg DB; Breese GR; Mailman RB; Frye GD; Mueller RA
Mol Pharmacol; 1979 Mar; 15(2):246-56. PubMed ID: 38389
[No Abstract] [Full Text] [Related]
19. Action in vitro and in vivo of chlorpromazine and haloperidol on cyclic nucleotide systems in mouse cerebral cortex and cerebellum.
Palmer GC; Jones DJ; Medina MA; Palmer SJ; Stavinoha WB
Neuropharmacology; 1978 Jul; 17(7):491-8. PubMed ID: 211456
[No Abstract] [Full Text] [Related]
20. Effects of ethanol, arecoline, atropine and nicotine, alone and in various combinations, on rat cerebellar cyclic guanosine 3',5-monophosphate.
Dodson RA; Johnson WE
Neuropharmacology; 1979 Nov; 18(11):871-6. PubMed ID: 233143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
